The Role of the Oncology Nurse in the Diagnosis and Treatment of Castleman Disease
November 30, 2021
November 30, 2022
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Global Education and Group Paradigm Medical Communications, LLC.
In collaboration with the Castleman Disease Collaborative Network.
This activity is supported by an educational grant from EUSA Pharma (US) LLC.
- Nurse Continuing Education — 1.0 contact hour of continuing education
- Nurse Practitioner Continuing Education — 1.0 contact hour of continuing education
- PA Continuing Education — maximum of 1.00 AAPA Category 1 CME credit
All other healthcare professionals completing this course will be issued a statement of participation.
This activity has been designed to address the educational needs of oncology nurses, including advanced practice nurses (APNs) and registered nurses (RNs). It will also benefit PAs and other clinicians who manage patients with Castleman disease.
Castleman disease (CD) is a rare group of heterogeneous lymphoproliferative disorders, many of which have an unknown underlying etiology. Owing to its rarity and unknown etiology, many oncology nurses are unaware of this disease, despite it often being managed by hematology/oncology clinics. As a result, this webinar aims to educate oncology nurses on CD so they, in turn, are equipped to educate, advocate for, and support patients through the diagnosis and treatment process.
After completing this activity, the participant should be better able to:
- Outline the signs and symptoms of CD as they relate to early diagnosis
- Describe US Food and Drug Administration-approved and guideline-recommended therapies for CD
David C. Fajgenbaum, MD, MBA, MSc
Assistant Professor of Medicine
Division of Translational Medicine and Human Genetics
Associate Director, Patient Impact
Penn Orphan Disease Center
Center for Cytokine Storm Treatment and Laboratory
University of Pennsylvania
Co-Founder and Executive Director
Castleman Disease Collaborative Network
Sudipto Mukherjee, MD, PhD, MPH
Director of Rare Cancers and Blood Diseases
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Gretchen A. McNally, PhD, ANP-BC, AOCNP
The Ohio State University
Arthur G. James Cancer Hospital
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and (name of other entity). Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.2 hour(s) of pharmacology).
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 11/30/2021 to 11/30/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-204142.
Term of Offering
This activity was released on November 30, 2021 and is valid for one year. Requests for credit must be made no later than November 30, 2022.
Disclosures of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
|Name of Faculty or Presenter||Reported Financial Relationship|
|David Fajgenbaum, MD, MBA, MSc||Grant Research Support: EUSA Pharma|
|Sudipto Mukherjee, MD, PhD, MPH||Consultant/Independent Contractor: Biophram |
International; Bristol-Myers Squibb Company; Celgene
Grant Research Support: Bristol-Myers Squibb Company;
Jazz Pharmaceuticals, Inc; Novartis
Honoraria: Bristol-Myers Squibb Company; Novartis
Speakers Bureau: EUSA Pharma; Novartis
Other: Abbvie Inc; Blueprint Medicines Corporation; Bristol-
Myers Squibb Company; Celgene Corporation; EUSA
Pharma; Genentech, Inc.; Novartis
|Gretchen A. McNally, PhD, ANP-BC, AOCNP||Nothing to disclose|
The planners and managers have the following relevant financial relationships with ineligible companies:
|Name of Planner or Manager||Reported Financial Relationship|
|Rhys Williams, MSN, FNP-C, RN||Nothing to disclose|
|Kristin Delisi, NP||Nothing to disclose|
|Lindsay Borvansky||Nothing to disclose|
|Andrea Funk||Nothing to disclose|
|Liddy Knight||Nothing to disclose|
|Ashley Cann||Nothing to disclose|
|Kim Rodriguez||Nothing to disclose|
|Paradigm Medical Communications, LLC staff members||Nothing to disclose|
Instructions for Participation and Credit
In order to receive credit for this activity, the participant must:
- Follow instructions to register or log in with your professional information and complete the pre-activity assessment
- View the online activity in its entirety
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
There is no fee required for participation in this activity.
Course Viewing Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader
Technical Support: If you have any technical problems or playback issues email us at email@example.com.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Paradigm Medical Communications, LLC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
© 2021 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.
If you have any questions or comments, please email us at firstname.lastname@example.org.